{
    "nct_id": "NCT06892678",
    "official_title": "DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma",
    "inclusion_criteria": "* Patients < 40 years of age at the time of enrollment\n* Diagnosis of relapsed osteosarcoma or relapsed Ewing sarcoma who have completed all planned therapy for their relapse, as described in the protocol, and have no evidence of disease\n* Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1, or 2\n* Adequate bone marrow function defined as:\n* Peripheral absolute neutrophil count (ANC) greater or equal to 750/microliters\n* Platelet count greater or equal to 75,000/microliters (transfusion independent)\n* Adequate renal function defined by serum creatinine based on age and gender\n* Adequate liver function defined as:\n* Total bilirubin ≤ 1.5 x the upper limit of normal (ULN) for age AND\n* SGPT (ALT) ≤ 5.0 x ULN for age. For this study the ULN is 45 U/L\nHealthy volunteers allowed\nMust have maximum age of 39 Years",
    "exclusion_criteria": "* Pregnant or breastfeeding females\n* Patients must not have an uncontrolled infection\n* Patients must not have any significant intercurrent illness",
    "miscellaneous_criteria": ""
}